China Pharma Holdings, Inc.
CPHI
$1.75
-$0.035-1.97%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.84% | -9.53% | 22.27% | -50.44% | 22.42% |
| Total Depreciation and Amortization | -26.51% | -35.70% | -5.74% | 0.75% | 5.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,824.39% | -124.17% | -87.88% | 238.08% | 41,300.00% |
| Change in Net Operating Assets | -81.85% | 217.89% | 56.69% | 142.31% | -194.84% |
| Cash from Operations | -124.23% | 607.45% | 35.35% | 87.58% | -2,524.22% |
| Capital Expenditure | -198.97% | -311.96% | 132.74% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.08% | -- | -- | -- | -- |
| Cash from Investing | 70.32% | -3,066.30% | 132.74% | -- | -- |
| Total Debt Issued | -- | 0.00% | -98.64% | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,129.41% | 0.00% | -1.45% | 0.00% | -77.30% |
| Foreign Exchange rate Adjustments | 91.59% | -729.41% | 282.14% | 16.42% | -113.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -133.33% | -345.63% | 79.30% | 82.99% | -1,183.33% |